Back to 
Qube Research & Technologies Ltd
Qube Research & Technologies Ltd
KNTEShowing 0 of 7 quarters
Position history for Qube Research & Technologies Ltd's holdings in KINNATE BIOPHARMA INC
As of its Q1 2024 13F, Qube Research & Technologies held 6,262 shares of KNTE (Kinnate Biopharma), worth $16,657. Qube Research & Technologies' 13F filings listed KNTE from Q2 2023 to Q1 2024, 4 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of KNTE: RA CAPITAL MANAGEMENT, L.P., FMR LLC